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Abstract

INTERVALS ESTIMATES IN RANDOM-EFFECTS MODELS
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.

Virginia Commonwealth University, 2008

Major Director
Jessica M. Ketchum
Assistant Professor Department of Biostatistics

In the pharmaceutical setting, it is often necessary to establish the shelf life of a
drug product and sometimes suitable to assess the risk of product failure at the desired
expiry period. The current statistical methodology use confidence intervals for the
predicted mean to establish the expiry period and prediction intervals for a predicted new
assay value or a tolerance interval for a proportion of the population for use in a risk
assessment. A major concern is that most methodology treat a homogeneous
subpopulation, say batch, either as a fixed effect and therefore uses a fixed-effects
regression model (Graybill, 1976) or as a mixed-effects model limited to balanced data
viii
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structures (Jonsson, 2003). However, batch is definitely a random effect as this fact has
been reflected by some recent methodology [Altan, Cabrera and Shoung (2005), Hoffman
and Kringle (2005)]. Thus, to assess the risk of product failure at expiry, it is necessary to
use tolerance intervals since they provide an estimate of the proportion of assay values
and/or batches failing at the expiry period. In this thesis, we illustrate the methodology
described by Jonsson (2003) to construct β-expectation tolerance limits for longitudinal
data in a random-effects setting. We underline the limitations of Jonsson’s approach to
constructing tolerance intervals and highlight the need for a better methodology.

1

Introduction

1.1. Introduction to Interval Estimates
Scientists and engineers frequently express the need to quantify the uncertainty
associated with a point estimate in order to make decisions from limited sample data.
They may wish to obtain more data prior to making a decision if their knowledge of the
uncertainty is imprecise. To quantify such uncertainty, interval estimates are constructed
around a point estimate. Three different types of interval estimates may be calculated
from sampled data. Depending upon the type of application, the analyst may choose a
confidence interval, a tolerance interval, or a prediction interval.
Using sample data, some researchers may be interested in estimating a confidence
interval, a range of values expected to encompass the population parameter of interest
with some specified level of confidence. One way to think about confidence intervals is
to consider drawing many samples (in the same manner) from a population. Each sample
yields its own estimate of the parameter of interest (e.g., the population mean) and
corresponding confidence interval with a selected or desired confidence coefficient (e.g.,
95%). In this repeated sense, approximately 95% of the confidence intervals will enclose
the population mean.
Similar to the confidence interval, a tolerance interval is a range of values
expected to contain a certain percentage of observations from a population on the
average. For example, one may be interested in determining a range of values expected to
encompass 90% of the population on the average.
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Confidence intervals and tolerance intervals are both interval estimates for
parameters of the population. A prediction interval is a range of values expected to
encompass a new (future) observation from the population with a specified level of
confidence. For example, one may be interested in determining a range of values
containing the next predicted value with 95% confidence.
In order to choose the most appropriate interval (confidence, tolerance, or
prediction), the analyst must decide whether the main interest of the application resides in
describing the population from which the sample has been selected or in predicting the
results of a future sample from the same population.

1.2. Motivation
In the pharmaceutical setting, it is often necessary to establish the expiry period of
a drug and sometimes suitable to assess the risk of product failure at the desired expiry
period. The Food and Drug Administration (FDA) guidelines (FDA, 1987) requires that a
minimum of three batches be tested in stability analysis to account for batch-to-batch
variability so that a single shelf life is applicable to all future batches manufactured under
similar circumstances. In addition to the estimation of the individual shelf life for each
batch, it is also desirable to establish a single shelf life for a drug product based on
combined stability data from all batches. The FDA guidelines requires that preliminary
tests of batch similarity be performed before combining the stability data from all
batches. A test for differences in the intercepts and differences in the slopes of
degradation lines among different batches is performed to evaluate batch similarity. The
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FDA recommends the 0.25 level of significance to test these hypotheses. Thus, the
single shelf life can be determined, based on the ordinary least-squares methods, as the
time point at which the 95% lower confidence bound for the mean degradation curve of
the drug characteristic intersects the approved lower specification limit.
If the hypotheses of equal intercepts and equal slopes are not rejected at the 0.25
level of significance, a single expiration dating period is usually estimated by fitting a
single degradation curve based on the pooled stability data of all batches under the
assumption that batch effects are fixed. If the hypotheses of equal intercepts and equal
slopes are rejected at the 0.25 level of significance, the FDA recommends determining a
single expiration dating period of the drug product based on the minimum of shelf lives
obtained from each batch. However, Chow and Shao (1991) showed that this method had
no statistical justification since the minimum approach is conservative and does not take
into account batch-to-batch variability.
Confidence intervals for the predicted mean are commonly used to establish the
expiry period of a drug product. Prediction intervals for a predicted new assay value and
tolerance intervals for a proportion of the population are sometimes used in risk
assessment. To assess the risk of product failure at expiry, it is more appropriate to use
tolerance intervals since they provide an interval estimate for the proportion of assay
values in the population failing at the expiry period.
The need for tolerance intervals was greatly emphasized during the first half of
the twentieth century. Wilks (1942) defined and constructed tolerance limits in the case
of normal distribution with unknown mean and variance. The use of tolerance intervals
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based on linear models became the interest of various researchers such as Wallis (1951),
Weissberg and Beatty (1960), Lieberman and Miller (1963), Ellison (1964), Howe
(1969), Graybill (1976). A procedure for establishing a two-sided tolerance interval based
on a balanced mixed-effects model was proposed by Liao and Iyer (2004). Under the
assumption of fixed batch effects, Hsu and Ruberg (1992) proposed a method to estimate
the expiration dating period of a drug product by using multiple comparison technique for
pooling stability data with the worst batch. The foregoing methodology (fixed batch
effects model) assumes that the drug characteristic decreases linearly over time. The
comparison of regression lines necessitates not only a test of equality of intercepts and
equality of slopes but also the equivalence of within batch variability. It should be
recognized, however, that the between-batch variation is often ignored during the
decision making process for pooling stability data across batches.
The FDA guidelines indicate that the batches used in long-term stability studies
for the establishment of drug shelf life should constitute a random sample from the
population of future production batches. The FDA also requires that all estimated
expiration dating periods should be applicable to all future batches. Under these
assumptions, the statistical methods derived from the fixed-effects models may not be
appropriate. This is due to the fact that statistical inferences about the expiration dating
period obtained from a fixed-effects model can only be drawn from the batches under
study and cannot necessarily be applied to future or unobserved batches. The use of
statistical methods based on a random-effects model is therefore more appropriate for
establishing the expiration dating period for future production batches. Several
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researchers have gained interest in the use of tolerance intervals in random-effects
settings. Lemon (1977) and Mee and Owen (1983) considered the case of one-sided
tolerance intervals for balanced one-way random-effects models. This was soon followed
by an extension to the unbalanced random-effects model [see Bhaumick and Kulkarni
(1991,1996), Bagui et al. (1996)]. Two-sided tolerance intervals for balanced one-way
random-effects models were also considered by Mee (1984) and an extension for
unbalanced data was described by Beckman and Tietjen (1989) and Wang and Iyer
(1994). The computation of a one-sided tolerance limit for a one-way random-effects
model for both balanced and unbalanced data using the concept of a generalized
confidence interval explored by Weerahandi (1993, 1995) was extended by
Krishnamoorthy and Thomas (2004). Hoffman and Kringle (2005) proposed a
methodology for constructing two-sided tolerance intervals for general random-effects
models in both balanced and unbalanced cases. A procedure for constructing a two-sided
tolerance limits without the normality assumption for both balanced and unbalanced
ANOVA models by using a nested bootstrap method was proposed by Shoung et al.
(2005). However, all the aforementioned analytical methods are based on a crosssectional approach and therefore do not utilize the longitudinal structure of the data
(which can lead to more accurate tolerance intervals) or used distribution-free methods
which have limitations in small samples since they are based on order statistics. The last
two aforementioned methodologies [Hoffman and Kringle (2005), and Shoung et al.
(2005)] use the β-content tolerance intervals procedure which are mainly intended for
drugs where the risk of adverse side effects rapidly increases with an overdose, i.e. even a
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minor overdose may result in death (Petzold, 2001). Jonsson (2003) proposed a new
methodology that not only took into account the longitudinal structure of the data but also
used the β-expectation tolerance intervals procedure which are intended for drugs where
the expected outcome of an overdose may not cause death (Petzold, 2001). However,
Jonsson’s approach to tolerance intervals treats the slopes as a fixed effect and needs to
be enhanced since the random-effects slopes are of extreme importance to the
pharmaceutical industry.
In summary, the main difference between the fixed-effects models and the
random-effects models is that the random-effects model incorporates the fact that batches
are considered a random sample drawn from the population of all production batches,
including future ones if the process does not change. Hence, the intercepts and slopes
used to characterize the degradation of a drug product should be considered as random
variables.

1.3. Objective
The aim of the present work is to describe and illustrate tolerance interval
methods based on random-effects and fixed-effects models. We will also describe
methods for confidence intervals and prediction intervals based on fixed-effects models.
Methods for tolerance intervals in the random-effects setting will be based on those
described by Jonsson (2003) while models for tolerance intervals in the fixed-effects
setting will be based on those described by Wilks (1941) and Graybill (1976). In Chapter
2, we will introduce the fixed-effects model, the random-effects model, and the interval
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estimates. In Chapter 3, we will demonstrate the results from the methodology using an
analysis dataset. In Chapter 4, we will draw the conclusion from the analysis and make
suggestions for future research.

2

Methodology

2.1. Introduction
In this chapter, we introduce the fixed-effects model (Section 2.2) and the random-effects
model (Section 2.3). Methods for describing confidence intervals, prediction intervals,
and tolerance intervals are described in Sections 2.4, 2.5, and 2.6 respectively.

2.2. The Normal Fixed-Effects Model Definition
The fixed-effects model is of the form
y = Xα + ε,

(2.1)

where
y is an n × 1 vector of observed response values,
X is an n × p (n > p ) observed design matrix corresponding to the fixed-effects,

a is a p × 1 vector of fixed-effects parameters, and

ε is an n × 1 unobservable vector of residuals.
The residuals ε i , i = 1, … , n are assumed to be independent and identically
distributed N ( 0, σ 2 ) . Thus, the variance of y, var ( y ) = V is given by

V = var( Xα + ε )=var( ε )=σ 2 I , where I is an n × n identity matrix.
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2.3. The Normal Random-Effects Model Definition
The random-effects model introduced by Laird and Ware (1982) extends the fixed-effects
model in equation (2.1) such that

y = Xα + Zβ + ε ,

(2.2)

where

y , X , a , and ε are as defined in the fixed effects model,
Z is an n × q observed design matrix for the random-effects, and

β is the q × 1 vector of random-effects/coefficients parameters.
The covariance of y, var(y) = V given by V = var(Xα + Zβ + ε). This model assumes that
the random-effects and the residuals are independent so that

V = var(Xα) + var(Zβ) + var(ε).
Since α describes the fixed-effects parameters, var(Xα) = 0. Hence,

V = Zvar(β)Z’ + var(ε).
Under the assumption that the random-effects follow normal distributions and letting
var(β) = G we obtain

V = ZGZ’ + Σ,
where β ~N(0,G) and ε ~N(0,Σ).

(2.3)
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2.4. Confidence Interval Definition
For a fixed-effects simple linear regression model, consider estimating the mean response
of a population given particular values of the predictor x. A two-sided 100(1 – α)%
confidence interval for the mean response µY x0 is given by
( x0 − x ) 2
1
+
,
αs
1−
n n
2
2
∑ ( xi − x )

yˆ 0 ± t

(2.4)

i =1

where ŷ0
represents the estimate of the mean response at x = x0 ,
n is the population size, and

t

1−

α

is the 1 − α2 percentile of the central t-distribution with n-2 degrees of freedom.

2

2.5. Prediction Interval Definition
For the fixed-effects simple linear regression model, consider predicting the response of a
single future observation given particular values of the predictor x. A two-sided 100(1 –

α)% prediction interval for a single response value Y0 is given by
yˆ 0 ± t

1−

α s 1+
2

( x − x )2
1
+ n 0
,
n
2
∑ ( xi − x )
i =1

where

ŷ0 represents the estimate of the mean response at x = x0 ,
n is the population size, and

(2.5)
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t

1−

α

is the 1 − α2 percentile of the central t-distribution with n-2 degrees of

2

freedom.
Confidence intervals reflect the uncertainty in estimating the mean response
which is a function of the parameter estimates. Prediction intervals reflect the uncertainty
from the parameter estimates as well as the uncertainty of a future observation. This is
why prediction intervals are wider than confidence intervals. Comparing the two
formulae in equation (2.4) and equation (2.5), the prediction intervals include an extra
“1” in the square root which reflects the additional uncertainty.

2.6. Tolerance Interval
2.6.1

Introduction

In this section, we first define the tolerance interval introduced by Wilks (1941) as it
applies to cross-sectional data under the fixed-effects model. We then define the βcontent tolerance interval described by Graybill (1976) under the fixed-effects model as it
applies to longitudinal data. We finally describe the methods used for estimation of the βexpectation tolerance interval as it applies to longitudinal data in the normal randomeffects setting as it was introduced by Jonsson (2003).
Consider estimating a number γ p such that a (1 − p ) proportion of the responses in
the population under study is below it; or two numbers γ 1− p / 2,γ p / 2 such that
a (1 − p ) proportion of the responses in the population is between the two numbers. Let
the assay result (e.g., percent of label claim) be represented by a continuous random
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variable Y with cumulative distribution function F, and let w1 and w2 be defined by the
relation PY ( w1 < Y < w2 ) = F ( w1 ) − F ( w2 ) = β , where β is a predetermined probability. A

β-expectation tolerance interval requires that 100β% of the individual responses from the
batches fall between the estimated limits on the average; that is, the expectation over ŵ1
and ŵ2 , E ( PY ( wˆ 1 < Y < wˆ 2 ) ) , equals β exactly or at least approximately (Jonsson, 2003).
Though β-expectation tolerance intervals can be constructed with or without
distributional assumptions, distribution-free tolerance limits have limitations in small
samples, as they are based on order statistics (Y(r), Y(n-r+1)) with r < (n+1)/2.

2.6.2

Wilks’ Method for Tolerance Interval

Let the independent and identically distributed random variables Y1 ,… , Yn from a
normal distribution N(µ, σ2) represent a cross-sectional sample at some time. If Y is a new
observation from N(µ, σ2) and if Y and S2 are the unbiased estimators of µ and σ2,
respectively, then

1
Y −Y
is distributed as 1 + T( n −1) , where T( n −1) denotes a Student TS
n

variable with n-1 degrees of freedom. Hence, the β-expectation tolerance bounds at each
time point introduced by Wilks (1941) are of the form

Y ± KC S ,

(2.6)

where

KC = 1 +

1
t1+ β
n 2 ( n −1)

(2.7)
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and t1+ β
2

( n −1)

is the 100( 1+2β )-percentile in the distribution of T( n −1) .

2.6.3

Graybill’s Method for Tolerance Interval

For a fixed-effects simple linear regression model, consider finding a range of values
expected to contain a certain percentage of observations from a population with some
specified level of confidence. The Q th tolerance limits at the point x0 and with
confidence coefficient 1 − α is of the form

αˆ 0 + αˆ1 x0 ± gQσˆ

(2.8)

where gQ is given by

gQ = Atα :n − p ;(θ ) ,
A2 =

( x − x0 ) 2
1
+
,
n ∑ ( xi − x ) 2

tα :n − p ;(θ ) is the upper α probability point of the noncentral t distribution with n – p degrees
of freedom and noncentrality parameter θ =

2.6.4

NQ
A

.

Jonsson’s Method for Tolerance Interval

2.6.4.1 Introduction
A considerable improvement of Wilks’ method for tolerance intervals can be
achieved by utilizing the longitudinal structure of the data so that all the n subjects are
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used at each time point. Using the pharmaceutical stability framework, a mixed-effects
model, the variance components regression model, used by Jonsson (2003) is defined as
Yij = µ j + δ t i + ε ij , i = 1, …, T , j = 1, …, n ,

(2.9)

where
Yij is the assay result (percent label claim) for the jth batch at the ith time point,

µ j is a random-effect that reflects factors that are specific to the jth batch,
δ is a fixed-effect which expresses the change over time common to all batches,
ti represent the time points at which the response is defined, and

ε ij is a random residual that summarizes the effects of all factors that have not been
included in the model.
The β-expectation tolerance bounds at time t for the random-effects model are
given by

µˆ t ± Kˆ LVˆ ,

(2.10)

where µˆ t and Vˆ are estimators of the mean and the square root of the variance of Yij ,
respectively, and are based on all nT observations. The quantity Kˆ L depends on the time t
and is estimated from the data whereas KC in equation (2.7) is a constant across
time. Kˆ L is determined so that the β-expectation property holds.
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2.6.4.2 Estimation
The problem with constructing tolerance bounds using equation (2.9) are two
fold: to find a good estimator of V and to determine the value of Kˆ L , which depends upon
the distribution of

Yij − µˆ t
. One approach is to use a Taylor series approximation so that
Vˆ

the tolerance bounds have at least approximately the β-expectation property.
We assume that the µ j , j = 1, …, n, are identically distributed N(α, σU2) and the

εij, j = 1, …, n, i = 1, …, T, are identically distributed N(0, σε2). We also assume that
the µ j and the εij are independent of each other. Thus the Yij are N(α + δti, σU2 + σε2). The
tolerance interval is estimated as ( wˆ1 , wˆ 2 ) = ( µˆ i − Kˆ LVˆ , µˆ i + Kˆ LVˆ ) , where µˆ i = αˆ + δˆti is an
estimator of µi = α + δ ti and Vˆ is some unbiased estimator of V = σ U2 + σ ε2 .
Based on data from the jth batch, let αˆ j and δˆ j be the ordinary least squares estimators of α
n α
ˆj
and δ . The best unbiased estimators of α and δ, α̂ and δˆ , are given by αˆ = ∑
and
j =1 n

n

δˆ j

j =1

n

δˆ = ∑

, respectively. In addition, we define the corrected sum of squares as

T

T

ti
is the mean time. Then,
i =1 T

Wtt = ∑ (ti − t ) 2 , where t = ∑
i =1



σ U2 + σ ε2



n

αˆ + δˆti ∼ N  α + δ ti ,

+

σ ε2 (ti − t ) 2 
nWtt

.
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Let wˆ r' = µi ± K LVˆ , (r = 1, 2) be provisory estimators such that K L is an arbitrary
constant. Since V( wˆ r' ) = V( ŵ' ), using a Taylor series approximation we obtain
E ( F ( wˆ 2' ) − F ( wˆ1' ) ) ≈ F ( w2 ) − F ( w1 ) +

V(wˆ ' )
( F (2) ( w2 ) − F (2) ( w1 ) ) .
(
2

(2.11)

If we let F be the cdf of a normally distributed random variable with variance V2 and Φ
be the cdf of a corresponding standardized variable, we obtain the following three
relations:
F ( w2 ) − F ( w1 ) = 2Φ( K L ) − 1,

F (2) ( w2 ) − F (2) ( w1 ) =

-2K L exp{−
V 2 2π

K L2
}
2 , and

V ( wˆ ' ) = V ( µi ± K LVˆ ) = V (αˆ + δˆti ± K LVˆ )
= V (αˆ + δˆt ) + K 2V (Vˆ )
i

=
Thus,

2
U

2

σ +σε
n

L

2

+

σ ε (ti − t )2
nWtt

+ K L2V (Vˆ ).
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1  σ U2 + σ ε2 σ ε2 (ti − t ) 2 K L2V (Vˆ ) 
K L2
+
+
K
exp{
−
}

 L
2
nV 2Wtt
V2 
2
2π  nV
K L2
1  1 σ ε2 (ti − t ) 2 K L2V (Vˆ ) 
K
exp{
}
= 2Φ ( K L ) − 1 −
+
+
−

 L
2
nWtt
V2 
2
2π  n V

E ( F ( wˆ 2' ) − F ( wˆ1' ) ) = 2Φ ( K L ) − 1 −

1 σ
≈ 2Φ ( K L ) − 1 + 
2

= 2Φ ( K L ) − 1 −

1
2π

= 2Φ ( K L ) − 1 −

1
2π


K L2 
-2K
exp{
−
}
L

+ σ ε σ ε (ti − t )
2 
+
+ K L2V (Vˆ )  
n
nWtt
V 2 2π




 σ U2 + σ ε2 σ ε2 (ti − t ) 2 K L2V (Vˆ ) 
 K L2 
+
+


 K L exp −
2
nV 2Wtt
V2 
 2 
 nV
ˆ 
 1 σ ε2 (ti − t ) 2
 K L2 
2 V (V )
+ KL
.
 + 2
 K L exp −
nWtt
V2 
 2 
n V
(2.12)

2
U

2

2

2

2.6.4.2.1. Estimation of Vˆ
We define the following sums of squares:
n

T

WYY = ∑∑ (Yij − Y j ) 2 ,

(2.13)

j =1 i =1

n

T

WtY = ∑∑ (ti − t )(Yij − Y j ), and

(2.14)

j =1 i =1

n

S = ∑ (Y j − Y ) 2 .

(2.15)

j =1

n

If we define Y = ∑
j =1

Yj
n

, then,

σ2 χ 2
S
∼ (σ U2 + ε ) n −1 , and .
n −1
T n −1

σˆ ε2 =

WYY − δˆWtY
σ ε2
χ n2(T −1)−1.
∼
n(T − 1) − 1 n(T − 1) − 1

(2.16)
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Since

S
and σˆ ε2 are independent of each other and of α̂ and δˆ , an unbiased estimator
n −1

of V 2 = σ U2 + σ ε2 is given by
S
1
Vˆ 2 = σˆU2 + σˆ ε2 =
+ σˆ ε2 (1 − ).
n −1
T

(2.17)

Jonsson (2003, Table 1) shows that Vˆ 2 is in fact a biased estimator of V and therefore
needs to be corrected. Using a Taylor series expansion, the expectation of V is
V (Vˆ 2 )
V (Vˆ 2 )
E (Vˆ ) = E ( Vˆ 2 ) ≈ V 2 −
=
V
[1
−
].
8(V 2 )3/2
8(V 2 ) 2

(2.18)

This leads to the following adjusted estimator of V
−1

 V
(Vˆ 2 ) 
2
ˆ
 .
V 1 −
2 2
 8(V ) 
It follows from equations (2.16) and (2.17) that the variance of Vˆ 2 , V (Vˆ 2 ) , is of the form

1 
 S
V (Vˆ 2 ) = V 
+ σˆ ε2 (1 − ) 
T 
 n −1

σ ε2

1
T +
T )
=V(
n −1
n(T − 1) − 1
2
U

σ +

(σ U2 +
= 2[

σ ε2

T
n −1

This implies that

σ ε2 (1 − )

)2

1
T ].
+
n(T − 1) − 1

σ ε4 (1 − ) 2
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V (Vˆ 2 )
V (Vˆ 2 )
=
8(V 2 ) 2 8(σ U2 + σ ε2 )2

σ ε2

1
)2
σ ε4 (1 − ) 2
2
T
T
= [
+
]
2
2 2
8 (n − 1)(σ U + σ ε ) [n(T − 1) − 1](σ U2 + σ ε2 ) 2
(σ U2 +

1 (1 − R ) 2
R2
],
= [
+
4 n −1
n(T − 1) − 1
where
1
R = 2 T2 .
(σ U + σ ε )

σ ε2 (1 − )

(2.19)

Hence an estimator of V = σ U2 + σ ε2 is given by
−1


 1 − Rˆ 2

ˆ2
1
R


2
2

Vˆ = σˆU + σˆ ε 1 − 
+
 ,
 4 n −1
n
T
−
1
−
1
(
)






(

)

(2.20)

where
1

σˆ ε2 (1 − )  n(T − 1) − 3 
Rˆ = 2 T2 ⋅ 
.
σˆU + σˆ ε  n(T − 1) − 1 

(2.21)

This correction factor involving the estimator R̂ helps reduce the bias in small
samples since the ratio of the estimated variance components has an F-distribution.
Jonsson (2003) found through simulation studies that the uncorrected estimator of V has a
negative bias that decreases in absolute value with increasing values of n, and to a lesser
extent with increasing values of T.
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2.6.4.2.2. Estimation of Kˆ L
Using equation (2.12) and equating it to a predetermined value of β, we may get a
relationship between R and KL.

E ( F ( wˆ 2' ) − F ( wˆ1' ) ) = 2Φ ( K L ) − 1 −
1
2π

 


1 

 K L2 
(t − t )2  K L2  (1 − R )2
R
R2
1
+K
exp
+
+
+
+
 



−

L
Wtt  2  n − 1
n(T − 1) − 1 
 2 
 n  1− 1

T
 


=β
(2.22)
where R is given by (2.19).
We then use this relationship to find an estimated value of KL from an observed value of
R. We write a quadratic equation in R by equating (2.12) to the predetermined value β
since it is difficult to write KL as an explicit function of R. This quadratic equation has
one root of interest.
Let
C=

A=

(ti − t )2
, and
1
n(1 − )Wtt
T

2
2π (2Φ ( K L ) − 1 − β ) 1
[
− ],
2
K L2
KL
n
K L exp{− }
2

(2.23)

(2.24)

where C is a component that is determined by spacing of the time points at which the
measurements are made. For a given n and T, C=0 at t = t and reaches the maximum at
the end points of the range of t. (See Jonsson, 2003 for an example). We could note,
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however, that the maximum at the end points decreases with increasing T (Jonsson,
2003). Equation (2.22) becomes

1

(n(T − 1) − 1)[1 −
R=

(n − 1)C
(n − 1)C 2
] − [(n(T − 1) − 1)2 [1 −
] − (nT − 2)(n(T − 1) − 1)(1 − (n − 1) A)]2
2
2
KL
KL
.
nT − 2
(2.25)

There exists a one-to-one relationship between R ∈ (0,1) and KL ∈ I K L such that R
decreases with increasing KL. The quantity Kˆ L denotes the value of KL corresponding to
an estimated value of R given in (2.21). Jonsson (2003) states that KL becomes
empirically almost linearly dependent on

Z=

(1 − R) 2
R2
+
n −1
n(T − 1) − 1

(2.26)

provided the predetermined value (β) is 0.90 or 0.95. For larger values of β, especially for
small n, we fit KL to polynomial functions of Z. The estimation of KL is done using a
computer program which is found in the Appendix section.

2.6.4.3 β-Expectation Tolerance Interval
The estimated 95%-expectation tolerance interval in the population of random
batches at time t based on longitudinal data is of the form (αˆ + δˆt − Kˆ LVˆ , αˆ + δˆt + Kˆ LVˆ ) .
The values of Vˆ and Kˆ L are derived from equations (2.20) and (2.25) respectively.
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Applications

In this chapter, the methodology for estimation proposed in Chapter 2 is studied using an
example dataset. We demonstrate the results using a random-effects model with data
from a pharmaceutical stability data simulation which was performed by Obenchain
(1990).
Table 1: Data Structure
Observations Batch

Month

1

1

0

102.783

2

1

1

99.350

3

1

3

98.625

4

1

6

101.525

5

1

9

96.750

6

1

12

97.350

7

2

0

102.550

8

2

1

99.650

9

2

3

104.100

10

2

6

101.275

11

2

9

95.850

12

2

12

93.167

13

3

0

104.583

14

3

1

101.200

15

3

3

101.600

16

3

6

100.850

17

3

9

100.925

18

3

12

97.467

Y
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The data set represents measurements from three batches. Six replicate assay results,
expressed in percent label claim, were measured in months at different storage times,
specifically at times 0, 1, 3, 6, 9, and 12 months. Hence, the six time points (T=6) were
considered at t = 0, 1, 3, 6, 9, and 12. For all three batches, two replicate response values
were missing at times 1, 3, 6, and 9 months. For all three batches, the process begins with
a computation of the mean of the replicate assay results across the six replicates. The
dataset follows a structure as seen in Table 1.

3.1. Presenting Results from the Analysis
Recall that the confidence limits are of the form yˆ 0 ± t

1−

αs
2

( x − x )2
1
+ n 0
. We compute
n
2
∑ ( xi − x )
i =1

the 95% confidence interval for the mean of the assay results across the three batches at
time 0 month under the fixed-effects model to obtain the values 102.55 and 0.7694
for ŷ0 and se ( yˆ0 ) , respectively. Note that se ( yˆ0 ) = s

( x − x )2
1
+ n 0
. This yields a
n
2
∑ ( xi − x )
i =1

confidence interval of (100.92, 104.18). The 95% confidence intervals for the mean
response at the remaining time points are displayed in Table 2. Confidence intervals for
the random-effects model are not discussed in this thesis.
A 95% prediction interval that will contain a single future observation from a
( x0 − x )2
1
+
. For example if we were
α s 1+
1−
n n
2
2
∑ ( xi − x )

population of size n is of the form yˆ 0 ± t

i =1
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interested in predicting the response from a single future observation at month 0, then a
95% prediction interval is (97.83, 107.26). These intervals are computed for the fixedeffects model and the corresponding prediction intervals for months 1 – 12 are
summarized in Table 2. Prediction intervals for the random-effects model are not
discussed in this thesis.
Using the cross-sectional structure of the data under the fixed-effects model, the
95%-expectation tolerance of the responses for any batch in the population is of the

1
1
form Y ± K C S , where K C = 1 + t0.975(2) = 4.303 1 + = 4.303 × 1.1547 = 4.970 and
3
3
t1+ β
2

( n −1)

is the 100( 1+2β )-percentile in the distribution of T( n −1) . At month 0, this interval is

(97.78, 108.83). The tolerance intervals for the remaining time points can be found in
Table 3.

Recall that under the fixed-effects model, the 95% tolerance interval that contains
at least 95% of the population described by a normal distribution is of the form
(αˆ 0 + αˆ1 x0 − g Qσˆ , αˆ 0 + αˆ1 x0 + gQσˆ ) (Graybill, 1976). Using a longitudinal data structure
approach, the 95% tolerance interval that contains at least 95% of the population
described by a normal distribution under the fixed-effects model at month 0 is (95.61,
109.49). The tolerance intervals for the remaining time point are given in Table 3.
However, using the longitudinal structure of the data under the random-effects
model, the 95%-expectation tolerance interval of the responses for any batch in the
population is of the form µˆ t ± Kˆ LVˆ , where the values of Kˆ L are given in Table 3. Using the
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SAS Software, a regression analysis on the pairs (ti , Yij ) was done using a randomeffects model definition in PROC MIXED. The computation yielded the following
values:

Y = 102.78, t = 3.5, Wtt = 110.83,
B = 1.90, αˆ = 102.55, δˆ = −0.49724

σˆU = 0.25771, σˆ ε = 4.16493
At this point Kˆ L needs to be determined. Unfortunately, the expression in equation (2.25)
does not readily yield values for Kˆ L given R, n, T, C, and A. Instead, the expression is
solved for R by iterating through various values of Kˆ L at different time points. Fitting KL
to polynomial functions of Z using equation (2.26) gives Rˆ = 0.67266 and Vˆ = 2.14916
for equations (2.21) and (2.20) respectively. For example, let’s assume that a value of Kˆ L
corresponding to Rˆ = 0.6727 is desired to construct a 95% tolerance interval at t = 0
months. Let’s further assume that n = 3, T = 6, t and Wtt are given as aforementioned.
The computer program (see Appendix) gives a list of values of ( Kˆ L , Rˆ ) from which two
pairs are of our interest: (2.3793, 0.6724) and (2.3821, 0.6673). We conclude from these
two pairs that Kˆ L is found in the interval (2.3793, 2.3821) since R̂ belongs to the interval
(0.6673, 0.6724). Through a series of iteration of Kˆ L from 2.3793 to 2.3821 gives

( Kˆ L , Rˆ ) = (2.3809, 0.6720). Therefore, the solution is Kˆ L ≈ 2.3809 . The estimated 95%expectation tolerance interval for the response Y at month 0 under the random-effects
model is (97.43, 107.66). The variation in the intervals from one time point to another is
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due to the change in Kˆ L . The tolerance intervals are computed and given in Table 3.
Figure 1 shows a graph of the Jonsson’s, Wilks’, and Graybill’s tolerance intervals.

Table 2: 95% Confidence & Prediction Intervals
Wilks'

Month

Y

S.D.

S.E. Predicted

95% CI

95% P.I.

Yˆ

S

se ( yˆ0 )

Fixed

Fixed

0

103.31

102.55

1.1126

0.7694

(100.92, 104.18) (97.83, 107.26)

1

100.07

102.05

0.9930

0.6853

(100.60, 103.50) (97.39, 106.71)

3

101.44

101.06

2.7409

0.5510

(99.89, 102.22)

(96.48, 105.63)

6

101.22

99.56

0.3413

0.5012

(98.50, 100.63)

(95.01, 104.01)

9

97.84

98.07

2.7079

0.6593

(96.67, 99.47)

(93.43, 102.71)

12

96.00

96.58

2.4495

0.9242

(94.62, 98.54)

(91.74, 101.42)

Table 3: 95% Tolerance Intervals
95% T.I.
Random

Fixed

Fixed

(Jonsson)

(Graybill)

(Wilks)

0

(97.43, 107.66)

(95.61, 109.49)

(97.78, 108.83)

2.3809

1

(96.94, 107.16)

(95.23, 108.87)

(95.13, 105.00)

2.3768

3

(95.95, 106.16)

(94.43, 107.69)

(87.82, 115.06)

2.3768

6

(94.41, 104.71)

(92.99, 106.13)

(99.52, 102.91)

2.3969

9

(92.83, 103.31)

(91.29, 104.85)

(84.39, 111.30)

2.4381

12

(91.22, 101.94)

(89.39, 103.77)

(83.82, 108.17)

2.465

Month

Kˆ L

Figure 1: Tolerance Intervals
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3.2. Discussion and Summary of the Analysis
Under the fixed-effects model, the 95% confidence intervals for the mean of the assay
results across the three batches are narrower than the 95% prediction intervals. This is
mainly justified from the fact that the formula for the 95% prediction intervals include an
extra “1” which reflects the additional uncertainty that emanate from a future
observation. Tolerance intervals obtained under either the fixed-effects or random-effects
model using the longitudinal structure of the data are more appropriate than tolerance
intervals computed under the fixed-effects model using the data from a cross-section at
each time point. This is an evidence since the former does not use the entire data. Using
the longitudinal data structure, the tolerance intervals obtained from Jonsson’s method
under the random-effects model are narrower than the tolerance intervals obtained from
Graybill’s method under the fixed-effects model. The difference between the two types of
tolerance intervals is due to the fact that Graybill’s method for tolerance interval does not
incorporate a random effect into the model. We should also notice that there are some
fundamental differences between Jonsson’s method, Graybill’s method, and Wilks’
method for tolerance intervals. Jonsson’s method uses the concept of β-expectation
tolerance interval under the random-effects model for a longitudinal data structure; the
covariance structure is compound symmetry. Graybill’s method uses the concept of βcontent tolerance interval under the fixed-effects model for a longitudinal data structure;
the covariance structure does assume independence. Wilks’ method uses the concept of

β-expectation tolerance interval under the fixed-effects model for a cross-sectional data
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structure; no covariance structure is assumed under Wilks’ method. The tolerance
intervals for Jonsson’s, Wilks’, and Graybill’s methods are shown in Figure 1.
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4

Conclusions and Future Research

In this thesis, we described three types of intervals estimates using longitudinal
structured data. We first began by introducing the fixed-effects model which treated our
population parameter of interest as being fixed with respect to time. We built on the fact
that the population parameter of interest was in fact a random-effects parameter as was
indicated by most recent methodology. In fact, a major concern in the pharmaceutical
industry is that most methodology treats the batches as a fixed effects and therefore
ignores the between-batch variability. Inference made based on fixed-effects models are
not applicable to future or unobserved batches. Therefore, the use of statistical methods
based on a random-effects model (treating intercepts and/or slopes as a random-effects) is
more appropriate for establishing the expiry period applicable to future production
batches.
We illustrated the confidence intervals for the predicted mean, which are
commonly used to establish the expiry period of a drug product. We then described the
prediction intervals for a predicted new assay value and the tolerance intervals for a
proportion of the population which are sometimes used in risk assessment. However, it is
more appropriate to use tolerance intervals in order to assess the risk of product failure at
expiry since they provide an interval estimate for the proportion of assay values in the
population failing at the expiry period.
We focused our attention to the β-expectation tolerance interval, which requires
that 100β% of the individual responses from the batches fall between the estimated limits
on the average. We chose not to use the other type of tolerance interval, the β-content
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tolerance interval, because they are mainly intended for drugs where the risk of adverse
effects rapidly increases with an overdose such that even a minor overdose may result in
death (Petzold, 2001). Our choice of tolerance interval, the β-expectation tolerance
interval, is intended for drugs where the expected outcome of an overdose may only
cause discomfort (Petzold, 2001). Since our main interest is on over-the-counter
medications, the use of this type of tolerance interval is more appropriate. Furthermore,

β-content tolerance intervals appear to be too wide for samples when the within-batch or
the between-batch variability is large [Jonsson (2003), Hoffman and Kringle (2005)].
We compared tolerance intervals based on cross-sectional data to tolerance
intervals based on longitudinal data. This led us to the conclusion that it is more
appropriate to use tolerance intervals derived from longitudinal than those obtained from
cross-sectional data since the latter do not use the entire data. This was shown in greater
detail by Jonsson (2003).
We finally used the longitudinal data structure to compare tolerance intervals obtained
using Jonsson’s approach under the random-effects model to tolerance intervals using
Graybill’s method under the fixed-effects model. We found that the tolerance intervals
obtained from Jonsson’s method are narrower than the tolerance intervals obtained from
Graybill’s method. This weakness in Graybill’s methodology is due to the fact that it
does not incorporate a random effect into the model.
Thus, our findings have led us to a few limitations with the data used for the
purpose of the analysis and the methods used for the computation of the random-effects
tolerance intervals. In fact, most pharmaceutical stability data are limited when it comes
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to the number of batches used. Even though the FDA recommends that at least three
batches be used in the analysis of stability data, the minimum number of three batches
seems too small for the computation of statistical intervals. The dataset used in our
analysis which was performed by Obenchain (1990) falls in the same category. Due to
the small number of batches, the intervals computed are wide because of the large within
batch variation ( σˆ ε = 4.16493 ).
Longitudinal-based methods for computing statistical intervals cannot be used
without distributional assumptions. However, distribution-free methods are not
appropriate for small sample sizes.
The β-expectation tolerance interval presented by Jonsson (2003) is mainly
intended for small samples where there is a large within or between subjects variation.
This interval was proven to be superior to Wilks’ (1941) and Graybill’s approaches as the
lengths of the intervals are smaller on the average, while the β-expectation property is
simultaneously maintained. This is especially the case when the within subjects variation
is larger than the between subjects variation.
However, the methodology proposed by Jonsson (2003) needs further
improvement. Researchers need to allow for addition of the random slopes in the model
since the current approach only allows for random intercepts. This new methodology
should also account for the case of unbalanced data. A method could be developed to
incorporate the enhanced Jonsson’s approach to tolerance intervals in the SAS “MIXED”
procedure.
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Appendices

6.1. SAS Code
/**********************************************************************
****************
***********************************************************************
****************
Kakotan Sanogo
Under the Guidance of Drs. Jessica M. Ketchum,
Charles W. Kish,
and Ramakrishnan Viswanathan
Department of Biostatistics, Viginia Commonwealth
University
Division of Statistics, Wyeth Consumer Healthcare
Modified on: 11-Dec-2008
Dataset: Obenchain (1990)
References: Analysis of Messy Data, Miliken & Johnson, 2002
The Theory and Application of the Linear Model,
Graybill, 1976
A Longitudinal Approach for Constructing betaExpectation
Tolerance Intervals, Jonsson, 2003
Determination of Sample Sizes for Setting Tolerance
Limits, Wilks, 1941
***********************************************************************
***************
***********************************************************************
**************/

data rc;
input batch month r1-r6;
array r{6};
monthc = month;
drop i r1-r6;
do i = 1 to 6;
y = r{i};
if (y ^= .) then output;
end;
datalines;
1
0 101.2 103.3 103.3 102.1 104.4 102.4
1
1
98.8 99.4 99.7 99.5
.
.
1
3
98.4 99.0 97.3 99.8
.
.
1
6 101.5 100.2 101.7 102.7
.
.
1
9
96.3 97.2 97.2 96.3
.
.
1 12
97.3 97.9 96.8 97.7 97.7 96.7
2
0 102.6 102.7 102.4 102.1 102.9 102.6
2
1
99.1 99.0 99.9 100.6
.
.
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2
3 105.7 103.3 103.4 104.0
.
.
2
6 101.3 101.5 100.9 101.4
.
.
2
9
94.1 96.5 97.2 95.6
.
.
2 12
93.1 92.8 95.4 92.5
92.2 93.0
3
0 105.1 103.9 106.1 104.1 103.7 104.6
3
1 102.2 102.0 100.8 99.8
.
.
3
3 101.2 101.8 100.8 102.6
.
.
3
6 101.1 102.0 100.1 100.2
.
.
3
9 100.9 99.5 102.5 100.8
.
.
3 12
97.8 98.3 96.9 98.4 96.9 96.5
;
proc sort; by batch month;
proc means; by batch month;
var y;
output out = ymeans mean = y;
proc print data = ymeans;
run;
data test;
set ymeans(keep=batch month y);
proc print;
run;
***********************************************************************
********
***********************************************************************
********
COMPUTATION OF CONFIDENCE INTERVALS: FIXED-EFFECTS MODEL
***********************************************************************
********
***********************************************************************
********;
****** Method ONE;
proc mixed data = test;
class batch;
model y = month /solution outp = out1 outpm = out2 cl;
title '95% Confidence Intervals for the Fixed-Effects Model';
run;
proc print data = out2;
run;
****** Method TWO;
proc mixed data = test;
class batch;
model y = month /solution outp = out1 outpm = out2 cl;
title '95% Confidence Intervals for the Fixed-Effects Model';
estimate "time0" intercept 1 month 0/ cl df=16;
estimate "time1" intercept 1 month 1/ cl df=16;
estimate "time3" intercept 1 month 3/ cl df=16;
estimate "time6" intercept 1 month 6/ cl df=16;
estimate "time9" intercept 1 month 9/ cl df=16;
estimate "time12" intercept 1 month 12/ cl df=16;
run;
**** Method THREE;
proc glm data=test ;
model y=month / SS3 clm

;

*clm Prints 95% confidence
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intervals for the
mean of each observation ;
title '95% Prediction Intervals for the Fixed-Effects Model';
estimate "time0" intercept 1 month 0 ;
estimate "time1" intercept 1 month 1 ;
estimate "time3" intercept 1 month 3;
estimate "time6" intercept 1 month 6;
estimate "time9" intercept 1 month 9;
estimate "time12" intercept 1 month 12;
run;
***********************************************************************
********
***********************************************************************
********
COMPUTATION OF CONFIDENCE INTERVALS: RANDOM-EFFECTS MODEL
***********************************************************************
********
***********************************************************************
********;
*****Method ONE;
proc mixed data = test;
class batch;
model y = month / s cl outpm=predm ;
random int month/ sub=batch s g v;
title '95% Confidence Intervals for the Randam-Effects Model';
run;
proc print data = predm;
run;
******Method TWO;
proc mixed data = test;
class batch;
model y = month /solution outp = out1 outpm = out2 cl ;
random intercept month / sub = batch type = un solution v vcorr;
title '95% Confidence Intervals for the Randam-Effects Model';
estimate "time0" intercept 1 month 0/ cl df=12;
estimate "time1" intercept 1 month 1/ cl df=12;
estimate "time3" intercept 1 month 3/ cl df=12;
estimate "time6" intercept 1 month 6/ cl df=12;
estimate "time9" intercept 1 month 9/ cl df=12;
estimate "time12" intercept 1 month 12/ cl df=12;
run;
/*******************************************************************
*******************************************************************
COMPUTATION OF PREDICTION INTERVALS: FIXED-EFFECTS MODEL
*******************************************************************
*******************************************************************/
proc glm data=test;
model y=month / SS3 cli ;
*cli Prints 95% prediction
intervals for the mean
of each observation ;
title '95% Prediction Intervals for the Fixed-Effects Model';
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estimate
estimate
estimate
estimate
estimate
estimate

"time0" intercept 1 month 0 ;
"time1" intercept 1 month 1 ;
"time3" intercept 1 month 3;
"time6" intercept 1 month 6;
"time9" intercept 1 month 9;
"time12" intercept 1 month 12;

run;
/*******************************************************************
*******************************************************************
COMPUTATION OF PREDICTION INTERVALS: RANDOM-EFFECTS
*******************************************************************
*******************************************************************/
%let _time=Month;
%let _alpha=0.05;
proc mixed data =test ;
class batch ;
model y = &_time / s cl outpm=predm ;
random int &_time/ sub=batch s g v;
ods output solutionf=solutionf;
ods output solutionr=solutionr;
ods output covparms=covparms;
ods output dimensions=dim;
ods output tests3=tests3;
ods output nobs=nobs;
ods output ClassLevels=class;
run ;

/* PRINT DATASETS CREATED FROM PROC MIXED */
data dim2;
set dim;
do i=1 to 18 by 1;
if descr='Subjects' then
do;
n_subj=value;
df_intercept = n_subj - 1;
df_slope = n_subj - 1;
call symput('_n_subj', n_subj);
output;
end;
keep n_subj df_intercept df_slope;
end;
%put &_n_subj;
run;
proc print data=dim2;run;
***********************************************************************
CREATE A DATASET WITH NUMBER OBS USED IN ANALSIS AND
DEGREES OF FREEDOM FOR MSE
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*********************************************************************
**;
data nobs2;
set nobs;
do i=1 to 18 by 1;
if label="Number of Observations Used" then
do;
n_tot=n;
df_err = n_tot - (2*&_n_subj);
output;
end;
keep n_tot df_err ;
end;
run;
proc print data=nobs2;run;
***********************************************************************
*
CREATE DATASET OF INTERCEPT ESTIMATES USING PREDM DATASET
& MERGE WITH PREDM DATASET
***********************************************************************
;
data intercept;
set predm;
if &_time=0 then
do;
intercept=pred;
output;
end;
keep batch &_time intercept;
run;
proc print data=intercept;run;
proc sort data=intercept out=intercept; by batch;
proc sort data=predm out=predm; by batch;

data predm_int;
merge predm intercept;
by batch;
run;
proc print data=predm_int;run;
data predm_int2;
set predm_int(rename=(intercept=temp_int));
retain x .;
intercept=temp_int;
if temp_int ne ' ' then x = intercept;
else if temp_int = ' ' then intercept = x;
drop x temp_int;
run;
proc print data=predm_int2;run;
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***********************************************************************
*
CREATE DATASET OF SLOPE ESTIMATES USING PREDM DATASET
& MERGE WITH PREDM / INTERCEPT DATASET
***********************************************************************
;
data slope;
set predm_int2;
if &_time ne 0 then
do;
slope = (pred - intercept) / &_time;
output;
end;
keep batch &_time slope;
run;
proc print data=slope;run;
proc sort data=slope;
by batch descending &_time;
run;
proc sort data=predm_int2;
by batch descending &_time;
run;
data predm_int_slope;
merge predm_int2 slope;
by batch;
run;
proc print data=predm_int_slope;run;
data predm_int_slope2;
set predm_int_slope(rename=(slope=temp_slope));
retain x .;
slope=temp_slope;
if temp_slope ne ' ' then x = slope;
else if temp_slope = ' ' then slope = x;
drop x temp_slope;
run;
proc print data=predm_int_slope2;run;

***********************************************************************
*
CREATE A DATASET WITH MSE & MERGE WITH PREDICTED VALUES DATASET
***********************************************************************
;
proc print data=covparms;
run;
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data covparms2;
set covparms;
retain var_intercept var_slope var_err;
do i=1 to 18 by 1;
if covparm='Intercept' then var_intercept=estimate;
else if covparm="&_time" then var_slope=estimate;
else if covparm='Residual' then
do;
var_err=estimate;
output;
end;
drop covparm estimate;
end;
run;
proc print data=covparms2;run;

***********************************************************************
*
COMBINE PREDM/INTERCEPT/SLOPE, COVPARM, & NOBS ESTIMATES
***********************************************************************
;
proc sort data=predm_int_slope;
by batch descending &_time;
run;
data reg_est;
merge predm_int_slope2 covparms2 dim2 nobs2;
*by batch;
run;
proc print data=reg_est;run;
*****************************************************************
*******
RESTRUCTURE RANDOM EFFECT DEVIATES DATASET
***********************************************************************
;
proc sort data=solutionr out= solutionr;by batch ;
proc print data=solutionr;
run;

data solutionr2;
set solutionr;
by batch;
retain effect_i effect_s .;
if effect="Intercept" then effect_i=estimate;
else if effect ne "Intercept" then effect_s=estimate;
if last.batch then output;
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keep batch effect_i effect_s;
run;
proc print data=solutionr2;run;

***********************************************************************
*
COMBINE PREDM/INTERCEPT/SLOPE/COVPARM/NOBS WITH RANDOM EFFECT
DEVIATES ESTIMATES
***********************************************************************
;
proc sort data=solutionr2 out= solutionr2;by batch;
proc sort data=reg_est out= reg_est;by batch;
data reg_est2;
merge reg_est solutionr2;
by batch;
run;
proc print data=reg_est2;run;

***********************************************************************
*
COMPUTE LOWER PREDITION LIMIT
***********************************************************************
;
data reg_est3;
set reg_est2;
*** standard error of the predicted value based on the mixed
model;
*** assumes no covariance between intercept & slope;
var_pred_vc=var_intercept + ((&_time**2)*var_slope) + var_err;
*** degrees of freedom based on satterthwaites approximation;
num= ((var_intercept + ((&_time**2)*var_slope) + var_err)**2);
denom= ((var_intercept**2)/df_intercept) +
((((&_time**2)*var_slope)**2) / df_slope) + ((var_err**2) / df_err);
df_sw = num/denom;
fcrit=finv(1-&_alpha,2,df_sw);
* f-distribution check;
fcrit_ck=finv(1-&_alpha,2,70);
scheffe_pct_pt = sqrt(2*fcrit_ck);
piw=sqrt(2*fcrit)*sqrt(var_pred_vc);
*** compute 2-sided upper pred. limits about a future obs.;
pred_chk=intercept + (slope*&_time);
lpl = pred - piw;

43
upl = pred + piw;
int_width=upl-lpl;
run;
proc print data=reg_est3;run;

***********************************************************************
*
CREATE LISTING OF REGRESSION ESTIMATES AND RELEASE LIMITS (LOWER &
UPPER)
***********************************************************************
;
ods select all;
proc print data=reg_est3 label;
var &_time batch intercept SLOPE pred var_intercept
var_slope var_err
df_intercept df_slope df_err fcrit lpl upl int_width df_sw
var_pred_vc piw;
run;

/****************************************************************
***
*****************************************************************
**
COMPUTATION OF TOLERANCE INTERVALS: Wilks' Method
*****************************************************************
**
*****************************************************************
**/
data _stats;
input y1 y2 y3@@;
datalines;
102.783
102.55
104.583
99.35 99.65
101.2
98.625
104.1
101.6
101.525
101.275 100.85
96.75 95.85
100.925
97.35 93.167
97.467
;
run;
proc print data=_stats;run;
data wilks; set _stats;
*Computing the mean batch;
y_bar = mean(y1,y2,y3);
* Computing the standard deviation;
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SD = std(y1,y2,y3);
K = sqrt(1+1/3)*(4.303);
97.5 percentile

* where n=3 batches and 4.303 is the
in a t distribution

with 2 degrees of freedom;
LTL = y_bar - K*SD;
UTL = y_bar + K*SD;
run;
proc print data= wilks;
var LTL UTL SD y_bar;
run;
/*******************************************************************
*******************************************************************
COMPUTATION OF TOLERANCE INTERVALS: Graybill's Method
*******************************************************************
*******************************************************************/
proc sort data=rc; by batch month;
proc means; by batch month;
var y;
output out = ymeans mean = y;
proc print data = ymeans;
run;
data test;
set ymeans(keep=batch month y);
proc print;
run;
proc glm data=test;
model y=month / ss3;
output out=predcheck predicted=pred h=h;
run;
proc print data=predcheck;
run;
data work;
length method $9;
input method $& alpha p pred mse df h expiry;
/* the value of "pred", "mse", "df", and "h" are
obtained from the "glm" procedure output and "pred" and "h"
vary for different values of "expiry" (from 0 to 12 month).
P=0.05 represent the 95% of tolerance point with (1-alpha)=95%
confidence.
The dataset below computes the Graybill's Tolerance Interval
at month 0.
*/
cards;
Graybill
.05 .05 102.55 4.3582101 16
0.13584 0
;
run;
proc print data=work;
run;
data stats;set work;
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rootmse=mse**.5;
A=h**.5;
np=probit(1-(p/2));
deltau=-np/A;
tcritu=tinv(alpha/2, df, deltau);
gpu= - A * tcritu;
UTW=gpu * rootmse;
UTL = pred + (gpu * rootmse);
deltal=np/A;
tcritl=tinv(1-(alpha/2), df, deltal);
gpl= A * tcritl;
LTW=gpl * rootmse;
LTL = pred - (gpl * rootmse);
run;
proc print data=stats;
var LTL UTL;
run;

/*******************************************************************
*******************************************************************
COMPUTATION OF TOLERANCE INTERVALS: Jonsson's Method
*******************************************************************
*******************************************************************/
/****************************************************************
***
*****************************************************************
**
START GLOBAL MACRO
*****************************************************************
**
*****************************************************************
**/
* First run the global macro and then change the value of _time
to
get the tolerance intervals;
%macro bigone(_time, _n, _TotTimes);
%do _t=0 %to &_time %by 1;
data a;
set test;
i = month;
i2 = i*i;
Y2 = Y*Y;
iY = i*Y;
run;
proc sort;
by batch;
run;
proc means noprint sum;
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var i Y i2 Y2 iY;
by batch;
output out = sas1 sum = si sY si2 sY2 siY;
run;
proc print data = sas1;
run;
data b;
set sas1;
mt = si/&_TotTimes;
mYj = sY/&_TotTimes;
mYj2 =
mYj*mYj;
Wttj = si2-si*si/&_TotTimes;
WtYj = siY-si*sY/&_TotTimes; WYjYj = sY2-sY*sY/&_TotTimes;
bj = WtYj/Wttj;
aj = mYj-bj*mt;
run;
proc means noprint sum;
var bj aj mYj mYj2 Wttj WYjYj WtYj;
output out = sas2 sum = sbj saj smYj smYj2 sWttj sWYjYj
sWtYj;
run;
proc print data= sas2;
run;
/* totals */
data c;
set sas2;
b = sbj/&_n; a = saj/&_n; Wtt = sWttj/&_n; BYY = smYj2smYj*smYj/&_n;
vare = (sWYjYj-b*sWtYj)/(&_n*(&_TotTimes-1)-1); varu =
BYY/(&_n-1)-vare/&_TotTimes;
R = vare*(1-1/&_TotTimes)*(&_n*(&_TotTimes-1)3)/(vare+varu)/(&_n*(&_TotTimes-1)-1);
Z = (1-R)*(1-R)/(&_n-1)+R*R/(&_n*(&_TotTimes-1)-1);
V = sqrt(vare+varu)/(1-Z/4);
call symput('R', R);run;
proc print ;
var a b Z V R vare varu Wtt BYY;
run;
/****************************************************************
**************************
*****************************************************************
**************************
THIS MACRO CREATES K_hat for a given TIME POINT
*****************************************************************
**************************
*****************************************************************
*************************/

data d;
meanT = 2.0;

Wtt = 110.83;

beta = 0.95;

const = gamma(1/2)*sqrt(2);
do K = 2.0 to 3.0 by 0.0001;
C = (&_time - meanT)**2/&_n/(1-1/&_TotTimes)/Wtt;
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AA = 2*(const*(exp(K*K/2))*(2*probnorm(K)-1beta)/K-1/&_n)/K/K;
R_hat = ((&_n*(&_TotTimes-1)-1)*(1-(&_n-1)*C/K/K)sqrt((&_n*(&_TotTimes-1)-1)**2*(1-(&_n-1)*C/K/K)**2-(&_n*&_TotTimes2)*(&_n*(&_TotTimes-1)-1)*(1-(&_n-1)*AA)))/(&_n*&_TotTimes-2);
dif_R=abs(R_hat-&R);
output;
end;
run;
data e; set d; if dif_R=. then delete; run;
proc sort data=e; by dif_R; run;
data f; set e;
if _n_ ne 1 then delete;
call symput("K", K);run;
run;
proc print data = f;
var K;
title ' K_hat at Time &time when beta = 0.95';
run;

/****************************************************************
**************************
*****************************************************************
**************************
THIS MACRO CREATES TOLERANCE INTERVALS FOR EACH TIME POINT
*****************************************************************
**************************
*****************************************************************
*************************/
data ti;
set c d;
low_ti = (a+b*&_time)-&K*V;
up_ti = (a+b*&_time)+&K*V;
proc sort; by low_ti up_ti;
run;
data tol_int; set ti;
if low_ti=. then delete;
else if up_ti=. then delete;
run;
proc print data=tol_int;
var low_ti up_ti;
run;
run;quit;
%end;
%mend;
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%bigone(0,3,6); * change the value of _time in bigone(_time, _n,
_TotTimes) to
obtain the values of Kl and the tolerance intervals;
/*******************************************************************
*******************************************************************
END GLOBAL MACRO
*******************************************************************
*******************************************************************/
/*******************************************************************
*******************************************************************
PLOTS OF TOLERANCE INTERVALS
*******************************************************************
*******************************************************************/
data TI;
input t y Jonsson_low Jonsson_high Graybill_low Graybill_high Wilks_low
Wilks_high y_bar;
cards;
0
102.55
97.43 107.66
95.61 109.49
97.7771
108.834
103.31
1
102.05
96.94 107.16
95.23 108.87
95.1333
105
100.07
3
101.06
95.95 106.16
94.43 107.69
87.8229
115.06
101.44
6
99.56 94.41 104.71
92.99 106.13
99.5211
102.912
101.22
9
98.07 92.83 103.31
91.29 104.85
84.387
111.296
97.84
12
96.58 91.22 101.94
89.39 103.77
83.8237
108.166
96
;
* The following exports the data into microsoft excel;
ods html file = 'C:\Documents and
Settings\sanogok\Desktop\THESIS\thesis.xls' ;
proc print data =TI;
title 'Tolerance Intervals' ;
run ;
ods html close ;
* The excel statemtents for creating the plot are the following ;
* For y_hat
=SERIES(Sheet1!$B$1,Sheet1!$A$2:$A$7,Sheet1!$B$2:$B$7,1);
* For Jonsson_low
=SERIES(Sheet1!$C$1,Sheet1!$A$2:$A$7,Sheet1!$C$2:$C$7,1);
* For Jonsson_high
=SERIES(Sheet1!$D$1,Sheet1!$A$2:$A$7,Sheet1!$D$2:$D$7,1);
* For Graybill_low
=SERIES(Sheet1!$E$1,Sheet1!$A$2:$A$7,Sheet1!$E$2:$E$7,1);
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* For Graybill_high
=SERIES(Sheet1!$F$1,Sheet1!$A$2:$A$7,Sheet1!$F$2:$F$7,1);
* For y_bar
=SERIES(Sheet1!$I$1,Sheet1!$A$2:$A$7,Sheet1!$I$2:$I$7,1);
* For Wilks_low
=SERIES(Sheet1!$G$1,Sheet1!$A$2:$A$7,Sheet1!$G$2:$G$7,5);
* For Wilks_high
=SERIES(Sheet1!$H$1,Sheet1!$A$2:$A$7,Sheet1!$H$2:$H$7,5);
* t represents the x-asis and y the y-axis;
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